Perrigo Sales Reach Record Highs Despite Manufacturing Restrictions
This article was originally published in The Tan Sheet
Executive Summary
Acquisitions and new products helped Perrigo grow quarterly revenue 23% to $718 million, despite manufacturing restraints related to an FDA warning letter.